#United States #New York #Rosen Law Firm #securities lawsuit #Park Ha

Investor Alert: Lead the Class Action Against Park Ha Biological Technology

The Rosen Law Firm has issued an important reminder for investors of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) who incurred significant losses. If you purchased securities of Park Ha between December 27, 2024, and July 8, 2025, you may have the opportunity to lead a class action lawsuit against the company. The deadline to move the court is September 28, 2026.

Why This Lawsuit Matters

This class action arises due to serious allegations surrounding Park Ha's business practices and the information disclosed to investors. According to the filed lawsuit, during the class period, the defendants are accused of making materially false statements and failing to disclose critical adverse facts about the company’s operations and the true activities surrounding its stock trading. The allegations emphasize that the company was entangled in a fraudulent stock promotion scheme, heavily relying on misleading information due to social media misinformation and fake financial representations.

Investors were left in the dark about essential risks related to the company’s shares, and it has been pointed out that Park Ha’s IPO was intentionally designed with a very narrow public float, facilitating potential manipulation of the stock price. As a result, many investors might have been misled regarding the company’s prospects and operations.

Steps to Take for Affected Investors

Affected investors are strongly encouraged to consider joining this class action. To participate, you can visit the Rosen Law Firm's dedicated webpage for this case: Join the Class Action or contact Phillip Kim, Esq. at 866-767-3653 for more information on how to proceed with your claim.

It's crucial to understand that to act as the lead plaintiff, you must formally move the court by the deadline. The role of a lead plaintiff is significant, as this person represents the interests of all class members in directing the litigation.

Why Choose Rosen Law Firm

The Rosen Law Firm has established itself as a leading authority in representing global investors through its effective litigation in securities class actions. The firm's portfolio demonstrates a strong track record, including the largest securities class action settlement against a Chinese company. Notably, Rosen Law Firm has also been consistently recognized for its achievements in obtaining recoveries for investors, including securing over $438 million in 2019 alone.

Investors are advised to choose qualified counsel with a proven history in managing complex litigations and achieving favorable settlements. Many firms may not possess the requisite experience or resources to competently lead such cases, often serving merely as intermediaries.

Conclusion and Next Steps

In summary, if you're an investor who bought shares of Park Ha Biological Technology during the defined time frame and experienced losses exceeding $100,000, this lawsuit presents an opportunity to seek significant compensation. Acting promptly and consulting the right legal counsel can enhance your chances of recovery.

Make sure to keep updated on any developments regarding the case by following the Rosen Law Firm on LinkedIn, Twitter, and Facebook. For any further inquiries, contact details are provided below:

• - Laurence Rosen, Esq.
• - Phillip Kim, Esq.
• - The Rosen Law Firm, P.A.
• - 275 Madison Avenue, 40th Floor
• - New York, NY 10016
• - Toll-Free: 866-767-3653
• - Email: email protected]
• - Website: [www.rosenlegal.com

Remember, no class has been certified yet, and until then, you are not represented unless you retain counsel. Make informed choices and safeguard your interests as this legal scenario unfolds.